Last reviewed · How we verify
KM-001 cream 1% 16 weeks treatment.
KM-001 cream 1% 16 weeks treatment. is a Small molecule drug developed by Kamari Pharma Ltd. It is currently in Phase 1 development. Also known as: Experimental drug administration-cohort 2.
At a glance
| Generic name | KM-001 cream 1% 16 weeks treatment. |
|---|---|
| Also known as | Experimental drug administration-cohort 2 |
| Sponsor | Kamari Pharma Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC (PHASE1)
- Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KM-001 cream 1% 16 weeks treatment. CI brief — competitive landscape report
- KM-001 cream 1% 16 weeks treatment. updates RSS · CI watch RSS
- Kamari Pharma Ltd portfolio CI
Frequently asked questions about KM-001 cream 1% 16 weeks treatment.
What is KM-001 cream 1% 16 weeks treatment.?
KM-001 cream 1% 16 weeks treatment. is a Small molecule drug developed by Kamari Pharma Ltd.
Who makes KM-001 cream 1% 16 weeks treatment.?
KM-001 cream 1% 16 weeks treatment. is developed by Kamari Pharma Ltd (see full Kamari Pharma Ltd pipeline at /company/kamari-pharma-ltd).
Is KM-001 cream 1% 16 weeks treatment. also known as anything else?
KM-001 cream 1% 16 weeks treatment. is also known as Experimental drug administration-cohort 2.
What development phase is KM-001 cream 1% 16 weeks treatment. in?
KM-001 cream 1% 16 weeks treatment. is in Phase 1.
Related
- Manufacturer: Kamari Pharma Ltd — full pipeline
- Also known as: Experimental drug administration-cohort 2
- Compare: KM-001 cream 1% 16 weeks treatment. vs similar drugs
- Pricing: KM-001 cream 1% 16 weeks treatment. cost, discount & access